1. Home
  2. ELVN vs FWRG Comparison

ELVN vs FWRG Comparison

Compare ELVN & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • FWRG
  • Stock Information
  • Founded
  • ELVN 2016
  • FWRG 1983
  • Country
  • ELVN United States
  • FWRG United States
  • Employees
  • ELVN N/A
  • FWRG N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • FWRG Restaurants
  • Sector
  • ELVN Health Care
  • FWRG Consumer Discretionary
  • Exchange
  • ELVN Nasdaq
  • FWRG Nasdaq
  • Market Cap
  • ELVN 927.8M
  • FWRG 970.4M
  • IPO Year
  • ELVN 2020
  • FWRG 2021
  • Fundamental
  • Price
  • ELVN $21.36
  • FWRG $16.35
  • Analyst Decision
  • ELVN Strong Buy
  • FWRG Strong Buy
  • Analyst Count
  • ELVN 5
  • FWRG 11
  • Target Price
  • ELVN $39.60
  • FWRG $21.82
  • AVG Volume (30 Days)
  • ELVN 716.7K
  • FWRG 1.0M
  • Earning Date
  • ELVN 08-12-2025
  • FWRG 08-05-2025
  • Dividend Yield
  • ELVN N/A
  • FWRG N/A
  • EPS Growth
  • ELVN N/A
  • FWRG N/A
  • EPS
  • ELVN N/A
  • FWRG 0.17
  • Revenue
  • ELVN N/A
  • FWRG $1,055,701,000.00
  • Revenue This Year
  • ELVN N/A
  • FWRG $21.27
  • Revenue Next Year
  • ELVN N/A
  • FWRG $16.07
  • P/E Ratio
  • ELVN N/A
  • FWRG $95.28
  • Revenue Growth
  • ELVN N/A
  • FWRG 14.43
  • 52 Week Low
  • ELVN $13.30
  • FWRG $12.90
  • 52 Week High
  • ELVN $30.03
  • FWRG $22.71
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 55.84
  • FWRG 53.49
  • Support Level
  • ELVN $20.22
  • FWRG $14.84
  • Resistance Level
  • ELVN $24.11
  • FWRG $16.63
  • Average True Range (ATR)
  • ELVN 1.69
  • FWRG 0.68
  • MACD
  • ELVN -0.02
  • FWRG 0.15
  • Stochastic Oscillator
  • ELVN 53.58
  • FWRG 79.89

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About FWRG First Watch Restaurant Group Inc.

First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.

Share on Social Networks: